The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ficerafusp alfa with pembrolizumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: Updated results from an expansion cohort of an open-label, multicenter, phase 1/1b trial.
 
Christine Chung
Consulting or Advisory Role - AVEO; Bicara Therapeutics; Exelixis; Fulgent Pharma; Genmab; Johnson & Johnson/Janssen; Regeneron; Seagen
Research Funding - Acrivon Therapeutics (Inst); Regeneron (Inst)
 
Glenn Hanna
Employment - Dana-Farber Cancer Institute
Honoraria - Massachusetts Medical Society
Consulting or Advisory Role - Bicara Therapeutics; Boxer Capital; Bristol-Myers Squibb; Coherus Biosciences; Coherus Biosciences; Elevar Therapeutics; Grey Wolf Therapeutics; InhibRx; KSQ Therapeutics; Kura Oncology; Merck; Naveris; Nextech Invest; PDS Biotechnology; Remix Therapeutics; Replimune; Surface Oncology
Research Funding - Actuate Therapeutics (Inst); Adenoid Cystic Carcinoma Research Foundation (Inst); ASCO (Inst); Bicara Therapeutics (Inst); Bristol-Myers Squibb (Inst); Gateway for Cancer Research; Genentech (Inst); ImmunityBio (Inst); Kura Oncology (Inst); Regeneron (Inst); Secura Bio (Inst)
 
Dan Zandberg
Consulting or Advisory Role - Bicara Therapeutics; Blueprint Medicines; Coherus Biosciences; Coherus Biosciences; InhibRx; Macrogenics; Merck; Prelude Therapeutics; Seagen
Research Funding - Aduro Biotech (Inst); AstraZeneca (Inst); AVEO (Inst); Bicara Therapeutics (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); ISA Pharmaceuticals (Inst); Macrogenics (Inst); Merck (Inst); Novasenta (Inst)
 
Deborah Wong
Consulting or Advisory Role - Coherus Biosciences; Merck; RAPT Therapeutics
Research Funding - AstraZeneca/MedImmune (Inst); Bicara Therapeutics (Inst); BioNTech SE (Inst); Bristol-Myers Squibb (Inst); Elevar Therapeutics (Inst); Enzychem Lifesciences (Inst); Flamingo Pharma (Inst); FSTAR (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Hookipa Biotech (Inst); invoX pharma (Inst); Lilly; Lilly (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Regeneron (Inst); Sensei Biotherapeutics (Inst); TopAlliance BioSciences Inc (Inst)
 
Eric Sherman
Consulting or Advisory Role - AffyImmune Therapeutics; Blueprint Medicines; Eisai; Exelixis; Lilly; UpToDate
Research Funding - Fore Biotherapeutics (Inst); HUTCHMED (Inst); Lilly (Inst); Novartis (Inst); Regeneron (Inst)
 
Assuntina Sacco
Employment - Moores Cancer Center
Consulting or Advisory Role - Tempus
Research Funding - ALX Oncology (Inst); AstraZeneca (Inst); Bicara Therapeutics (Inst); Genentech/Roche (Inst); Infinity Pharmaceuticals (Inst); ITeos Therapeutics (Inst); Janssen Oncology (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Merus (Inst); Regeneron (Inst); Seagen (Inst); Toragen (Inst)
 
Tamara Sussman
Research Funding - Bicara Therapeutics; Privo Technologies
 
Alberto Hernando-Calvo
Honoraria - Slingshot insights
Consulting or Advisory Role - Karger Publishers
Research Funding - Gilead Sciences (Inst)
 
Ralf Reiners
Employment - Bicara Therapeutics
Stock and Other Ownership Interests - Bicara Therapeutics
 
David Bohr
Employment - Bicara Therapeutics
Stock and Other Ownership Interests - Bicara Therapeutics; Bristol Myers Squibb Foundation; Gilead Sciences; Johnson & Johnson/Janssen
 
Rachel Salazar
Employment - Bicara Therapeutics
Stock and Other Ownership Interests - Bicara Therapeutics
Travel, Accommodations, Expenses - Bicara Therapeutics
 
Brenda O'Connell
Employment - Bicara Therapeutics
 
David Raben
Employment - Bicara Therapeutics
Stock and Other Ownership Interests - Bicara Therapeutics
 
Jeltje Schulten
Employment - Bicara Therapeutics
Stock and Other Ownership Interests - Bicara Therapeutics
 
John Kaczmar
Stock and Other Ownership Interests - HCA Healthcare (I)
Honoraria - The Scienomics Group; Triangle Insights Group
Consulting or Advisory Role - Coherus Biosciences; EMD Serono/Merck; PDS Biotechnology; Rakuten Medical